quinidine has been researched along with alprenolol in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (41.94) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (25.81) | 29.6817 |
| 2010's | 9 (29.03) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brincat, JP; Broccatelli, F; Carosati, E; Cruciani, G; Frosini, M; Kaatz, GW; Neri, A; Sabatini, S | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Norris, RM | 1 |
| Schroeder, JS | 1 |
| Himori, N; Izumi, A | 1 |
| Wood, M | 1 |
| Gettes, LS | 1 |
| Singh, BN | 1 |
| Gibson, DG | 1 |
| Aberg, A; Ulvenstam, G; Vedin, A; Wilhelmsson, C | 1 |
| Levi, GP; Proto, C; Quadri, A; Rovetta, A | 1 |
| Heeg, E; Reuter, N | 1 |
| Levi, GF; Proto, C | 1 |
| Forsbeck, M; Olin, R; Stejskal, VD | 1 |
| Bender, F | 1 |
3 review(s) available for quinidine and alprenolol
| Article | Year |
|---|---|
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Cardiac Surgical Procedures; Chlorpromazine; Dipyridamole; Disopyramide; Etidocaine; Female; Fentanyl; Half-Life; Humans; Imipramine; Kidney Diseases; Lidocaine; Liver; Mathematics; Meperidine; Methadone; Myocardial Infarction; Orosomucoid; Prazosin; Pregnancy; Propranolol; Protein Binding; Quinidine; Serum Albumin; Sex Factors | 1986 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Drug Therapy, Combination; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Myocardial Infarction; Oxprenolol; Physical Exertion; Propranolol; Quinidine; Receptors, Adrenergic; Sotalol; Tachycardia, Paroxysmal | 1970 |
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiac Output; Catecholamines; Glycolysis; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Humans; Lipid Metabolism; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Quinidine; Receptors, Adrenergic; Regional Blood Flow; Renin; Structure-Activity Relationship; Vasomotor System | 1974 |
1 trial(s) available for quinidine and alprenolol
| Article | Year |
|---|---|
Clinical uses of calcium ion antagonists in arrhythmias.
Topics: Adult; Aged; Alprenolol; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Child, Preschool; Clinical Trials as Topic; Female; Gallopamil; Humans; Male; Propylamines; Quinidine; Tachycardia, Paroxysmal; Tiapamil Hydrochloride; Verapamil | 1980 |
27 other study(ies) available for quinidine and alprenolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA.
Topics: | 2012 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Prophylactic antiarrhythmic drugs after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Age Factors; Alprenolol; Anti-Arrhythmia Agents; Humans; Middle Aged; Myocardial Infarction; Practolol; Quinidine; Recurrence | 1976 |
Should premature ventricular beats be treated in the ambulatory patient? A protagonist's view.
Topics: Adult; Aged; Alprenolol; Ambulatory Care; Cardiac Complexes, Premature; Death, Sudden; Electrocardiography; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Procainamide; Quinidine; Risk; Tachycardia; Ventricular Fibrillation | 1977 |
Change in automaticity of excised, sino-atrial node by alprenolol and its dextro isomer and several drugs injected into the sinus node artery of the dog.
Topics: Adenosine; Alprenolol; Animals; Calcium; Dogs; Female; Heart Rate; Injections, Intra-Arterial; Male; Nifedipine; Procaine; Propranolol; Quinidine; Sinoatrial Node; Stereoisomerism; Tetrodotoxin | 1977 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Failure; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Quinidine; Stereoisomerism; Structure-Activity Relationship | 1973 |
[Indications for long term treatment of ventricular arrhythmias].
Topics: Alprenolol; Arrhythmias, Cardiac; Death, Sudden; Digitalis Glycosides; Electrocardiography; Humans; Long-Term Care; Phenytoin; Practolol; Procainamide; Quinidine | 1974 |
[Combination of beta-blockaders and quinidine in the treatment of atrial fibrillation. Electrocardiographic aspects after restoring the sinus rhythm].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Arrhythmia, Sinus; Atrial Fibrillation; Drug Combinations; Electrocardiography; Humans; Propranolol; Propylamines; Quinidine; Sympatholytics | 1972 |
[Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria].
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Atrial Function; Drug Interactions; Electric Stimulation; Guinea Pigs; Male; Muscle Contraction; Phenytoin; Procainamide; Propranolol; Quinidine; Reserpine; Sparteine; Sympatholytics; Time Factors; Verapamil | 1971 |
Combined treatment of atrial fibrillation with quinidine and beta-blockers.
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Atrial Fibrillation; Chronic Disease; Drug Combinations; Drug Synergism; Electrocardiography; Humans; Indoles; Propranolol; Quinidine; Sympatholytics; Time Factors | 1972 |
Diagnosis of drug-induced occupational allergy by lymphocyte transformation test.
Topics: Alprenolol; Ampicillin; Chlormethiazole; Dermatitis, Occupational; Drug Hypersensitivity; Humans; Lymphocyte Activation; Metoprolol; Occupational Diseases; Quinidine | 1983 |